|
|
|
| Webinar: The Next Frontier in mRNA: Modular Manufacturing for Scalable RNA-LNP Therapies | mRNA therapeutic manufacturers face challenges around mRNA products encapsulated in lipid nanoparticles (LNPs). Learn more about the Centre for Process Innovation’s first UK GMP-ready site, and how it meets diverse RNA product demands. Hear how new sustainable approaches for second-generation mRNA-LNP manufacturing are addressing manufacturing challenges and accelerating RNA-based vaccine and therapy development. |
|
|
|
|
By Tyler Menichiello, contributing editor | In this segment of the executive roundtable discussion, our panelists discuss the growing prevalence of AI and its implications, both good and bad. They share their thoughts on smart adoption and the need for regulatory guidance moving forward. |
|
|
|
|
|
|
|
| Viral Vectors: Are We There Yet? | Article | By Caitlyn Smith and Ratish Krishnan, MilliporeSigma | What must we do as an industry to continue the momentum of cell and gene therapies and ensure these revolutionary treatments become a reality for patients who need them? |
|
|
| Get Full Control Of Your T Cell Isolation | Application Note | By Marine de Lageneste, Melissa Maggioni, Genna Luciani, et al., Cytiva | This study demonstrates the automated magnetic isolation of CD4/CD8+ cells from fresh or frozen leukapheresis using a functionally closed cell processing system paired with a modular application. |
|
|
|
|
|
|
|
|
| With over 450 unique products in clinical development and 50 anticipated approvals by 2030, the evolving regulatory landscape for cell and gene therapies is more critical than ever. Don't miss your chance to gain expert insights! Join the next Cell & Gene Live for an exclusive digital panel discussion exploring forward-looking perspectives on this transformative field. Registration is free—thanks to the support of Thermo Fisher Scientific. |
|
|
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|